Infection caused by canine distemper virus (CDV) is a highly contagious disease with high incidence and lethality in the canine population. Antiviral activity of flavonoids quercetin, morin, rutin and hesperidin, and phenolic cinnamic, trans-cinnamic and ferulic acids were evaluated in vitro against the CDV using the time of addition assay to determine which step of the viral replicative cycle was affected. All flavonoids displayed great viral inhibition when they were added at the times 0 (adsorption) and 1 h (penetration) of the viral replicative cycle. Both quercetin and hesperidin presented antiviral activity at the time 2 h (intracellular). In the other hand, cinnamic acid showed antiviral activity at the times 0 and 2 h while trans-cinnamic acid showed antiviral effect at the times À1 h (pre-treatment) and 0 h. Ferulic acid inhibited CDV replicative cycle at the times 0 and 1 h. Our study revealed promising candidates to be considered in the treatment of CDV. Structural differences among compounds and correlation to their antiviral activity were also explored. Our analysis suggest that these compounds could be useful in order to design new antiviral drugs against CDV as well as other viruses of great meaning in veterinary medicine.
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Introduction
Canine distemper is caused by a single stranded RNA virus of the genus Morbillivirus, family Paramyxoviridae. In dogs, canine distemper virus (CDV) can result in gastrointestinal and/or respiratory clinical signs, often accompanied by neurological signs . Although there are commercial vaccines against canine distemper, the disease remains one with the highest incidence and lethality in dogs (Rodeheffer et al., 2007) . The virus has been reported in wild animals (ferrets, wild dogs, foxes, coyotes, hyenas, lions, tigers, leopards, seals, sea lions and dolphins) Kennedy, 1998; Murphy et al., 1999; Moro et al., 2004) . The domestic dog is most commonly infected, and although the disease has been also found in big cats, the domestic cat is not susceptible .
Currently, therapeutic studies for CDV have employed either synthetic inhibitors that interfere with morbillivirus replication (Scagliarini et al., 2006; White et al., 2007; Elia et al., 2008; Yoon et al., 2008; Dal Pozzo et al., 2010) or natural compounds that display anti-CDV activity in vitro at early and/or late stages of viral replication (Gallina et al., 2011; Bagla et al., 2012) .
Phenolic compounds are plant secondary metabolites widely distributed among plant species and are targets of great scientific interest due to their pharmacological properties and therapeutic value (Schnitzler et al., 2008) . The compounds have antioxidant, anti-allergic, anti-inflammatory, anti-mutagenic, anticarcinogenic and antibacterial effects (Shon et al., 2004; Nafisi et al., 2008; Orhan et al., 2010; Shimosaki et al., 2011) . Flavonoids and phenolic acids, two major phenolic groups, have been reported to inhibit the replication of many viruses (Rees et al., 2008; Saha et al., 2009; Kim et al., 2010; Gravina et al., 2011) .
The antiviral activity of the flavonoid quercetin (3 0 ,4,3,5,7-pentahydroxil flavonol) has been reported for some viruses, including adenovirus 3 (AdV-3), herpes simplex virus (HSV) and influenza virus (Choi et al., 2009; Thapa et al., 2011) . Morin (2 0 ,4 0 ,3,5,7-pentahydroxil flavonol), another flavonoid, had antiviral action against equine herpesvirus 1 (EHV-1) (Gravina et al., 2011) . Antiviral activity of glycosidic flavonoids was shown by rutin (quercetin-3-Orutinoside) against HSV, dengue virus 2 (DENV-2) and human immunodeficiency virus (HIV) (Tao et al., 2007; Zandi et al., 2011) , and hesperidin against influenza virus (Saha et al., 2009) .
Both cinnamic acid and its trans isomers are phenolic acids or intermediate compounds in the synthesis routes of flavonoids (Yadav et al., 2008) . Phenolic acids have been reported to have antiviral effects against DENV, EHV-1 and HIV (Ichimura et al., 1999; Rees et al., 2008; Gravina et al., 2011) .
Some studies correlate changes in the structure of flavonoids with changes in their biological mechanisms. According to Kim et al. (2010) , isoquercetin, a glycosylated form of quercetin, showed higher inhibitory activity against influenza virus in vitro and in vivo than that reported for quercetin. Another study by Thapa et al. (2011) investigated the synthesis and antiviral activity of various derivatives of quercetin with hydroxyl substitutions at C-3, C-3 0 and C-5; synthetic analogs of quercetin demonstrated therapeutic index for influenza virus greater than that of quercetin.
Given the high impact of canine distemper disease upon the canine population as well as the lack of a specific antiviral treatment, the goal of the present work was to investigate natural compounds and their antiviral activity against CDV. We evaluated the in vitro inhibition of the CDV replicative cycle by the flavonoids quercetin, morin, rutin and hesperidin, and the phenolic acids cinnamic, trans-cinnamic and ferulic acids. Implications regarding structural differences of compounds and correlation with their antiviral activity were also considered.
Materials and methods

Cells and viruses
Vero cells were maintained in minimal essential medium (MEM) supplemented with 10% fetal bovine serum (SBF), penicillin (1.6 mg/L) and streptomycin (0.4 mg/L) at 37°C and 5% CO 2 . Canine distemper virus (strain Rockborn, 11th passage) was titrated by determining the infective dose for 50% tissue culture (TCID 50 ) , according to the method described by Reed and Muench (1938) .
Compounds
All seven phenolic compounds (quercetin, morin, rutin, hesperidin, cinnamic acid, trans-cinnamic acid and ferulic acid) were purchased from Sigma-Aldrich (Deisenhofen, Germany) (Figs. 8 and 9). Compounds were initially dissolved in dimethylsulfoxide (DMSO) to a stock concentration of 10 mg/mL and stored at 4°C. When needed, compounds were diluted in MEM at the time of use to provide working concentrations.
Cytotoxicity assays
The cytoxicity of the phenolic compounds was determined by microscopic evaluation searching for changes in cell viability and morphology. Non-toxic concentrations were also confirmed by a variation of the colorimetric method based on reduction of the salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma-Aldrich, Deisenhofen, Germany) by mitochondrial enzymes described by Mosmann (1983) . Briefly, Vero cells were seeded into 96-well microplates, and after four hours at 37°C different concentrations of each compound were added into media and analyzed after 72 h. Effect on cell morphology was observed microscopically, then cells were washed twice with phosphate buffered saline (PBS) pH 7.2 and incubated with MTT solution (1 mg/ mL) for four hours. Subsequently, the formed salt was dissolved by adding DMSO (100 mL/well) followed by shaking for 15 min at 37°C. Microplates were again incubated at 37°C for 1 h. Optical densities (OD 550 ) were determined by an ELISA reader (Bio-Tek, EL X 800). Six wells were evaluated for each compound concentration and untreated control. The percentage of viable treated cells was calculated based on untreated controls (% of control cells = OD exp /OD control cells Â 100). The 50% cytotoxic concentration (CC 50 ) was defined as the compound concentration required to reduce the absorbance by 50% of the cell control.
Time of addition assays
The study was performed according to the method described by Serkedjieva and Ivancheva (1999) with some modifications. Briefly, 96-well microplates seeded with monolayers of Vero cells (1 Â 10 5 cells/well) were individually supplemented with quercetin, morin, rutin, hesperidin, cinnamic acid, trans-cinnamic acid and ferulic acid at different times based on time of infection. The first set of plates was treated for 1 h prior to viral infection (time À1 h: pre-treatment effect). Cells were then washed twice with PBS followed by infection with serial dilutions of CDV (10-10 5 TCID 50 /mL). The second set of microplates were both infected and treated with the compounds followed by incubation at 4°C for 1 h to prevent virus internalisation (time 0 h: adsorption effect), after which the microplates were incubated at 37°C. The third set of plates was infected and the compounds were then added after 1 h adsorption at 37°C (time 1 h: penetration effect). The last set of plates was treated two hours post-infection (hpi) (time 2 h: intracellular effect). Assays were performed in triplicate. The antiviral activity of compounds at all stages of the viral replicativo cycle was measured by reduction in viral yield after 72 h post treatment compared to untreated infected cells and calculated using the method of Reed and Muench (1938) . All antiviral assays were assessed under the same conditions with DMSO to evaluate the possible interference of this solvent. Ribavirin (RBV), a known positive control drug was assessed in parallel to validate the test. The 50% inhibitory concentration (IC 50 ) was defined as the compound concentration required to reduce viral CPE by 50% of the virus control. The selectivity index (SI) for the compounds was obtained by calculating the ratio of the CC 50 and IC 50 values for the virus replication at each time point.
Evaluation of compounds structures
Compounds were divided in two groups, flavonoids and phenolic acids, based on their characteristics and chemical properties. For each group we established the common concentration used in the time of addition assays in order to analyze their structural differences and correlated it to their antiviral activity. The following flavonoids were compared to each other at a common concentration of 30 lg/mL: (i) quercetin and morin, (ii) quercetin and rutin, (iii) quercetin and hesperidin, and (iv) rutin and hesperidin. For phenolic acids, a comparative analysis between (i) cinamic and trans-cinamic acids, and (ii) trans-cinamic and ferulic acids was perfomed at a concentration of 10 lg/mL.
Data analyses
Statistical analyses were performed using the program Statistical Analysis and Design of Experiments -SISVAR (Sisvar 5.1 Build 72, Federal University of Lavras, MG, Brazil). Cytotoxicity and time of addition assays were analyzed by ANOVA one-way and two-way ANOVA, respectively. CC 50 and IC 50 were calculated from a linear regression equation. The Tukey test was used to compare means. Values of p less than 0.05 were considered significant.
Results
Cytotoxic effect
The cytotoxicity of the evaluated compounds was determined by microscopic observation of cell morphology associated with the measurement of cell viability by the colorimetric method MTT. We observed that intensity and variety of cellular morphological changes (loss of monolayer, granulation, cytoplasmic vacuolisation, stretching and narrowing of the extensions as well as darkening of the cell edges) became more apparent with increasing concentrations of the compounds. Table 1 shows CC 50 values obtained from the cytotoxicity assays.
DMSO CC 50 was higher than the DMSO% used to dissolve the compounds, proving the absence of DMSO cellular toxicity against Vero cells at volumes used to dissolve the compounds. The phenolic compounds showed CC 50 values ranging from 115. 88 ± 11.19 (quercetin) to 195.90 ± 7.84 lg/mL (morin).
Time of addition assays
Antiviral activity of compounds was determined by time of addition assays. These tests had the purpose of investigating which step of the viral replicative cycle the compounds might be affecting. IC 50 and SI (CC 50 /IC 50 ) values obtained from the cytotoxicity and antiviral assays are shown in Table 1 .
No significant differences were observed in viral titres with DMSO at the highest concentration (0.8%) as a solvent for the compounds in time of addition assays (not shown data). DMSO concentrations did not interfere with antiviral activity exhibited by flavonoids and phenolic acids. A positive control with ribavirin (RBV), which affects the intracellular phase of the CDV replicative cycle, was also performed (Supplementary Fig. 1 ).
The IC50 and SI values of phenolic compounds exhibiting activity ranged from 3.56 ± 0.13 (ferulic acid, time 0 h) to 40.52 ± 1.69 lg/mL (morin, time 1 h) and from 4.44 (transcinnamic acid, time À1 h) to 41.6 (ferulic acid, time 0 h), respectively (Table 1) .
Our results showed that all flavonoids displayed antiviral activity against CDV. As demonstrated in Fig. 1 , quercetin reduced viral yield at times 0 h (EC 50 11.72 lg/mL and SI 9.88), 1 h (EC 50 12.66 lg/mL and SI 9.15) and 2 h (EC 50 13.94 lg/mL and SI 9.31). 10.41 lg/mL and SI 15.01; hesperidin: EC 50 11.09 lg/mL and SI 14.78) and 1 h (rutin: EC 50 13.45 lg/mL and SI 11.62; hesperidin: EC 50 13.92 lg/mL and SI 11.78). On the other hand, hesperidin had also shown antiviral effect at time 2 h (EC 50 21.63 lg/mL and SI 7.58) at the concentration of 30 lg/mL. Antiviral activity exhibited by rutin and hesperidin at time 0 h was greater than others affecting the times 1 and 2 h.
The three phenolic acids tested also showed inhibitory effects against CDV replication. As shown in Fig. 5 , antiviral effect of cinnamic acid was demonstrated at times 0 h (EC 50 4.46 lg/mL and SI 30.12) and 2 h (EC 50 6.18 lg/mL and SI 21.74), but cinnamic acid only showed a reduction in viral yield at 2 h only at a concentration of 10 lg/mL. Addition of trans-cinnamic acid (Fig. 6 ) led to reduction of viral titres at times À1 h (EC 50 37.27 lg/mL and SI 4.44) and 0 h (EC 50 23.11 lg/mL and SI 7.16) at the concentration of 60 lg/ mL. Fig. 7 shows the antiviral action of ferulic acid at times 0 h (EC 50 3.56 lg/mL and SI 41.6) and 1 h (EC 50 3.63 lg/mL and SI 40.8), with no statistical differences between them.
Analyses of antiviral activity versus chemical structure
To facilitate structural evaluation of compounds related to their antiviral effects, we chose equal working concentrations for the flavonoids (30 lg/mL) and phenolic acids (10 lg/mL) in the time of addition assays. Establishment of efficient relationships between phenolic compounds was important to understand the variation of the inhibitory effects based on changes in their chemical structures. According to data presented in Table 2 , flavonoids that exhibited greater antiviral activity were rutin and hesperidin, affecting the stage of adsorption; there was no significant difference between them. Quercetin and hesperidin showed inhibitory effect at almost all viral replicative cycle stages, except in the stage prior to infection. Quercetin and hesperidin were also the only flavonoids that displayed similar antiviral activity in the intracellular stage.
Among phenolic acids evaluated ferulic acid had the highest inhibitory activity against CDV in the stages of adsorption and penetration with no significant differences between them (Table 3) . Cinnamic acid, on the other hand, was the only phenolic that showed inhibition in the intracellular viral stage. Trans-cinnamic acid did not show antiviral activity against CDV at the same working concentration as the other compounds.
Discussion
In the present study several flavonoids (quercetin, morin, rutin, and hesperidin) and phenolic acids (cinnamic, trans-cinnamic, and ferulic acids) were evaluated regarding their in vitro ability to inhibit stages of the CDV replicativo cycle. All flavonoids and phenolic acids demonstrated antiviral action against CDV. The observed inhibitory effects of flavonoids in the stages of adsorption and penetration suggest a direct inactivation of the virus, perhaps by binding to viral particles in an irreversible manner or by destabilizing viral ligands that are essential to the infectious process, such as envelope glycoproteins. Consequently, the role of flavonoids in the early stages of viral replication would reduce the number of infected cells and the formation of viral progeny. Furthermore, selectivity index (SI) greater than 3 indicates potential antiviral activity for compounds derived from plants (Chattopadhyay et al., 2009 ). All phenolic compounds evaluated in the present work exhibited SI values equal or greater than 3 (Table 1) . Quercetin and hesperidin inhibited the intracellular phase of CDV replication cycle. It has been demonstrated that quercetin and some other flavonoids can inhibit viral polymerase and interfere with the synthesis of viral nucleic acid (Formica and Regelson, 1995; Cushnie and Lamb, 2005) . Interference by such phenolic compounds in the CDV post-infection stage has also been demonstrated by Gallina et al. (2011) ; the phenolic dimer proanthocyanidin A2 resulted in both reduction of viral RNA synthesis and viral progeny, suggesting that the replicative complex may be affected.
On the other hand, Formica and Regelson (1995) correlated the antiviral property of quercetin with its ability to bind to envelope glycoproteins and the viral capsid. Moreover, Schnitzler et al. (2008) showed that quercetin bound to glycoproteins of the viral envelope which blocked the host cell-virus interaction. According to Kim et al. (2010) quercetin showed a reduction of influenza virus A replication in the early stages of infection. Other studies with flavonoids and tannins showed similar results at the stages of adsorption and penetration of different viruses (Kuo et al., 2009; Gravina et al., 2011) . The structural similarities among flavonoids might imply similar inhibitory mechanisms.
All phenolic acids evaluated in this study also demonstrated antiviral properties against CDV. Cinnamic acid derivatives have been reported to have antiviral effects against DENV (Rees et al., 2008) as well as EHV-1 in stages of pre-treatment and adsorption ⁄⁄ Concentration is statistically different compared to untreated control (p < 0.01). (Gravina et al., 2011) . This antiviral action may be due to a direct action to inactivate viral particles and/or cellular receptors, perhaps leading to their destabilization or blocking virus-cell interaction.
Cinnamic acid is a precursor in the synthesis of flavonoids and other phenolic acids, demonstrating a positive correlation between phenolic structures and antiviral properties. Phenolic compounds are reported to have high affinity for proteins, forming unstable complexes (Haslam, 1996) . Therefore, the antiviral effects of flavonoids in the early and post-infectious stages of CDV cycle can be applied to phenolic acids which have inhibitory mechanisms through interaction with viral envelope glycoproteins (Schnitzler et al., 2008) , or inhibition of viral polymerase with consequent interference in viral genome synthesis (Formica and Regelson, 1995; Cushnie and Lamb, 2005) .
In this study, we also analyzed the structural differences among compounds in order to investigate whether it was correlated with antiviral activity which might be useful for the design of new antiviral drugs. The structural similarity between quercetin and morin may be related to the results observed in our study since they were able to inhibit the stages of adsorption and penetration (Table 2 , Fig. 8 ). Both flavonoids belong to the flavonol class and the only structural difference between them is the hydroxyl position in ring B; morin has hydroxyls at C-2 0 and C-4 0 (meta), quercetin at C-3 0 and C-4 0 (ortho). Thus, absence of antiviral action in the postinfection phases for morin might be related to the position of the hydroxyl at C-2 0 , which might prevent its biological effects on CDV. Rutin, another flavanol, also has a chemical structure similar to quercetin; however, it is glycosylated in the C-3 position of the ring C (Fig. 8) . It is still unclear how these flavonoids specifically act, but this structural difference between the two might have contributed to the antiviral effect of rutin in the adsorption stage which was greater than that of quercetin.
Hesperidin is classified in the flavonones class due to the absence of a double bond between C-2 and C-3 in ring C. Similar to quercetin, it also presents substitutes in the same positions of ring B (C-3 0 and C-4 0 ), but hesperidin is glycosylated at the hydroxyl of C-7 in ring A (Fig. 8) . Although the structural similarity explains the inhibitory effects, which were statistically identical for penetration and intracellular replication, the sugar existent in the hesperidin might be responsible for the greater antiviral activity compared to quercetin in the adsorption step.
When comparing rutin and hesperidin, both have ortho substitutions in positions C-3 0 and C-4 0 in ring B and antiviral effects at the stages of adsorption and penetration (Fig. 8) . The difference in the structural sugar insertion for these two flavonoids might be related to the intracellular viral inhibition stage. Since this inhibition was observed only for hesperidin it is possible that the antiviral mechanism is related to the position of the sugar in the C-7 hydroxyl of ring A. The greatest antiviral activity was demonstrated for the glycosylated flavonoids in the stage of adsorption, suggesting that the sugar present in the polyphenolic compounds had more affinity to bind to viral structures important to the onset of infection.
Phenolic acids evaluated in our study also possess considerable structural similarity. Cinnamic and trans-cinnamic acids are geometrical isomers; however, the trans isomer form lacked antiviral effect since trans-cinnamic acid did not present antiviral action at the lowest working concentration (Table 3 , Fig. 9 ). On the other hand, the cis isomer form of cinnamic acid provided interference in the stages of adsorption and intracellular viral replicative cycle. Ferulic acid differs from trans-cinnamic acid only by the presence of substitutes in C-4 and C-5 of the aromatic ring, and these structural differences might be related to the antiviral effects in the stages of adsorption and penetration compared to trans-cinnamic acid. Structural differences of ferulic acid in relation to trans-cinnamic acid might be responsible for an increase in its affinity for cellular receptors and/or viral fusion proteins, which would also amplify its inhibitory mechanism during the viral adsorption phase. Our results showed that ferulic acid exhibited the greatest antiviral activity when compared to cinnamic acid.
Phenolic compounds evaluated here revealed significant antiviral activity against CDV. Further analysis will determine whether those promising candidates can be considered in the treatment of CDV as well as for the development of antiviral drugs against other viruses of significance in veterinary medicine such as measles virus, since both are genetically related (Summers and Appel, 1994; Rudd et al., 2006; Rodeheffer et al., 2007) . Our analysis of the relationship between chemical structures of compounds and their antiviral activities may indicate putative sites that might be used as models for designing new antiviral agents. Future experiments are still required to determine the inhibitory mechanism displayed by flavonoids and phenolic acids in order to assess their applicability in the treatment of CDV-infected animals.
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